跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
易瑞欧 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Elranatamab Injection
Approved
生物制品
Elranatamab Injection
PFIZER INC.
🇨🇳 National Medical Products Administration
Approval Date
Mar 4, 2025
Approval ID
8jXhuVnQzxh
Company
PFIZER INC.
Type
生物制品
Approval Details
Approval Id
8jXhuVnQzxh
Approval Number
国药准字SJ20250010
Generic Name
埃纳妥单抗注射液
Generic Name En
Elranatamab Injection
Trade Name
易瑞欧
Drug Type
生物制品
Dosage Form
注射剂
Strength
44mg(1.1mL)/瓶
Reg Date
2025-03-04
Expired Date
2030-03-03
Company Name
PFIZER INC.
Production Company Name
Pharmacia & Upjohn Company LLC
Company Detail Path
/organization/pfizer-inc
Production Company Detail Path
/organization/pharmacia-and-upjohn-company-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 4, 2025
Approval ID
8jXhuVnQzxh
Type
生物制品
Back to NMPA Approvals